These benefits, along with a previous report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the strategy of focusing on ACKR3 as a unique strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar disorders. These success suggest that https://vasilievichi284zrl0.illawiki.com/user